SCHEMBL8995751

SCHEMBL8995751

O=Cc1ccc(Cl)cc1.[NaH]

nearest known ligand 0.94

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.94
ALDH1A1 P00352 6/20 0.50
CYP2A6 P11509 5/20 0.50
TYR P14679 1/20 0.50
ALDH5A1 P51649 1/20 0.50
ABAT P80404 1/20 0.50
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.46
KDM4E B2RXH2 2/20 0.44
AHR P35869 1/20 0.44
CYP2A13 Q16696 1/20 0.44
MAOB P27338 1/20 0.44
FBP1 P09467 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1919 0.97
SCHEMBL27737708 0.94
Hydrochloric Acid SCHEMBL5255687 0.94 HSD17B10 (0.94) HSD17B10ALDH1A1CYP2A6TYRALDH5A1
Hydrogen Sulfide SCHEMBL27481476 0.94 HSD17B10 (0.94) HSD17B10ALDH1A1CYP2A6TYRALDH5A1
SCHEMBL28981622 0.94 HSD17B10 (0.94) HSD17B10ALDH1A1CYP2A6TYRALDH5A1
SCHEMBL28191020 0.94 HSD17B10 (0.94) HSD17B10ALDH1A1CYP2A6TYRALDH5A1
SCHEMBL31544783 0.94 HSD17B10 (0.94) HSD17B10ALDH1A1CYP2A6TYRALDH5A1
Fluoride SCHEMBL28312830 0.94 HSD17B10 (0.94) HSD17B10ALDH1A1CYP2A6TYRALDH5A1
Ethane SCHEMBL2154693 0.92 HSD17B10 (0.89) HSD17B10ALDH1A1CYP2A6TYRALDH5A1
Ethylene SCHEMBL27951982 0.92 HSD17B10 (0.89) HSD17B10ALDH1A1CYP2A6TYRALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104892405-A Method for extracting para-chlorobenzoic acid from ketene wastewater ZHANGJIAGANG CITY ZHENFANG CHEMICAL CO LTD 2015-09-09 CN disclosed
EP-0523100-B1 O6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY US HEALTH (US) 1996-08-28 EP disclosed
US-5358952-A Anticarcinogenic agents THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1994-10-25 US disclosed
US-5352669-A Increases host responsiveness to anti-neoplastic alkylating agents including chloroethylating agents for chemotheraputical treatment THE OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1994-10-04 US disclosed
EP-0523100-A4 O?6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O?6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY US HEALTH (US) 1993-03-17 EP disclosed
EP-0523100-A1 O?6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O?6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY. US HEALTH (US) 1993-01-20 EP disclosed
US-5091430-A Increase response to antitumor agents THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1992-02-25 US disclosed
WO-1991013898-A1 O6-BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) 1991-09-19 WO disclosed